Carotid Plaque Age Is a Feature of Plaque Stability Inversely Related
                    to Levels of Plasma Insulin by Hägg, Sara et al.
Carotid Plaque Age Is a Feature of Plaque Stability
Inversely Related to Levels of Plasma Insulin
Sara Ha ¨gg
1,2, Mehran Salehpour
3, Peri Noori
4, Jesper Lundstro ¨m
1,2,G o ¨ran Possnert
3, Rabbe
Takolander
5, Peter Konrad
5, Stefan Rosfors
6, Arno Ruusalepp
7, Josefin Skogsberg
1,2, Jesper Tegne ´r
4,
Johan Bjo ¨rkegren
1,2*
1The Cardiovascular Genomics Group, Department of Medical Biochemistry and Biophysics, Solna, Karolinska Institutet, Stockholm, Sweden, 2Clinical Gene Networks AB,
Stockholm, Sweden, 3Ion Physics, Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden, 4The Computational Medicine Group, Department of
Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden, 5Department of Surgery, So ¨dersjukhuset, Karolinska Institutet, Stockholm,
Sweden, 6Department of Clinical Physiology, So ¨dersjukhuset, Karolinska Institutet, Stockholm, Sweden, 7Department of Cardiac Surgery, Tartu University Hospital, Tartu,
Estonia
Abstract
Background: The stability of atherosclerotic plaques determines the risk for rupture, which may lead to thrombus formation
and potentially severe clinical complications such as myocardial infarction and stroke. Although the rate of plaque
formation may be important for plaque stability, this process is not well understood. We took advantage of the atmospheric
14C-declination curve (a result of the atomic bomb tests in the 1950s and 1960s) to determine the average biological age of
carotid plaques.
Methodology/Principal Finding: The cores of carotid plaques were dissected from 29 well-characterized, symptomatic
patients with carotid stenosis and analyzed for
14C content by accelerator mass spectrometry. The average plaque age (i.e.
formation time) was 9.663.3 years. All but two plaques had formed within 5–15 years before surgery. Plaque age was not
associated with the chronological ages of the patients but was inversely related to plasma insulin levels (p=0.0014). Most
plaques were echo-lucent rather than echo-rich (2.2460.97, range 1–5). However, plaques in the lowest tercile of plaque age
(most recently formed) were characterized by further instability with a higher content of lipids and macrophages (67.8612.4
vs. 50.466.2, p=0.00005; 57.6626.1 vs. 39.8625.7, p,0.0005, respectively), less collagen (45.366.1 vs. 51.169.8, p,0.05), and
fewer smooth muscle cells (130631 vs. 141621, p,0.05) than plaques in the highest tercile. Microarray analysis of plaques in
the lowest tercile also showed increased activity of genes involved in immune responses and oxidative phosphorylation.
Conclusions/Significance: Our results show, for the first time, that plaque age, as judge by relative incorporation of
14C, can
improve our understanding of carotid plaque stability and therefore risk for clinical complications. Our results also suggest
that levels of plasma insulin might be involved in determining carotid plaque age.
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Introduction
Atherosclerosis is believed to be a life-long chronic inflamma-
tory disease initiated at locations of turbulent blood flow, where
lipid-laden macrophages accumulate in the arterial wall and
eventually form mature plaques [1]. The cellular content and
relative amount of fat and collagen in the plaques is thought to
determine the risk of spontaneous plaque rupture [2,3]. In the
coronary arteries, plaque rupture can lead to thrombus formation
and myocardial infarction. A thrombus formed after carotid
plaque rupture can cause transient ischemic attacks (TIAs) or
stroke. In humans, the progression of carotid atherosclerosis (i.e.,
plaque growth) can be estimated by the intima-media thickness
(IMT) assessed by noninvasive B-mode ultrasound [4]. IMT has
also been shown to predict future cardiovascular events, such as
TIA, stroke, and even myocardial infarction [5,6]. However, the
role of IMT as a marker of plaque stability (i.e., risk of rupture) has
been questioned. For instance, young individuals with increased
IMT have a lower absolute risk for clinical events [6]. Other
ultrasound characteristics of carotid plaques have been sought to
assess carotid plaque stability. On such characteristic is the degree
of echogenicity [7]. Echo-lucent plaques are lipid- and macro-
phage-rich, signs of instability that are associated with a greater
risk of clinical symptoms than echo-rich plaques, which are fibrotic
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18248and calcified, hallmarks of stable plaques [7]. Echo-lucent plaques
are also associated with increased oxidative stress and inflamma-
tion independent of IMT [8].
Since extensive nuclear bomb tests in the 1950s and 1960s
leading to a rapid increase in atmospheric concentrations of
carbon-14 (
14C), the
14C concentration has steadily been declining
[9]. This curve of declination can now be used to our advantage
allowing dating of biological materials synthesized over the last five
to six decades. Through isolation of
14C from any biological
sample using accelerator mass spectrometry (AMS), it is possible to
determine its relative content of
14C that can be mapped on to the
declination curve determining the year of synthesis.
The role of tissue age for physiological functions and
pathological dysfunctions, is not very well understood. A reason
for overseeing age aspect of biology is most likely the lack of
reliable technologies to estimate the average age of cells and
tissues. However, as a result of recent developments it is now
possible to
14C date small (mg) amounts of biological samples
[10,11]. These improvements have already lead to several major
contributions to science improving our understanding of fat cell
and cardiomyocyte turnover with consequences for risk of diseases
in these tissues [12,13]. In addition, for certain types of diseases,
like atherosclerosis and cancer tumors that also are containing
necrotic biological material processed both within and outside cells
and thus remaining in the lesions across many cell generations,
14C
dating of the entire disease lesion is likely to provide a better
understanding of the development of these diseases over time and
therefore risk for clinical implications than
14C dating DNA alone
[12,13].
In the current study, we determined the average age of carotid
plaques using AMS to estimate the relative incorporation of
14Ci n
the core of plaques from 29 well-characterized symptomatic
patients with carotid stenosis. We hypothesized that carotid plaque
age (i.e. the average formation time of the plaques) could be an
important feature of plaque stability (as determined by immuno-
histochemistry (IHC)) and, as such, indicate the risk of clinical
events. We also sought associations between average plaque age
and the clinical phenotypes of the patients as well as gene
expression phenotypes of the plaques. The latter being assessed by
using Affymetrix GeneChip microarrays. We found that a low
plaque age, (reflecting a shorter plaque formation time) was
characterized by IHC features of unstable plaques. A lower plaque
age was also associated with higher levels of plasma insulin and of
gene activity related to oxidative phosphorylation and immune
responses.
Results
The biological age of carotid plaques determined by
14C
dating
The cores of plaques isolated from the common carotid arteries
of symptomatic patients (e.g., TIA) [14] were
14C dated. The
principle of
14C dating of biological samples is shown in Fig. 1A. In
brief, the levels of atmospheric
14C have been gradually declining
since the nuclear bomb tests in the 1950s and 1960s. The curve of
declination can be used to measure the time of biosynthesis and
thus the average biological age of any living matter formed during
this period (i.e. the formation time). This includes different
components of the body as well as disease processes, like plaque
formation. The average age of the plaque cores in our study was
9.663.3 years (n=29).
The patient-to-patient variation of carotid core formation,
reflected by the standard deviation of 3.3 years, was surprisingly
low given the heterogeneity of the biological materials (e.g., lipids
and collagen) and cell types in the core, suggesting a more
regulated and controlled formation than expected. None of the
samples were older than 15 years and in .93% (27/29) of the
patients, the cores were formed 5 to 15 years before surgery
(Fig. 1B). Two patients had a plaque age of 2 and 4 years,
respectively.
14C dating of carotid plaque cores divided into two
halves isolated from two additional patients showed a low intra-
sample variation; the average age differences between the two core
halves in these two patients were 0.9 year and 0.6 years,
respectively.
Echogenicity and IHC characteristics of the carotid
plaques
The average echogenicity of the carotid plaques as determined
by Gray-Weale scale (2.2460.97, range 1–5, with 1 being echo-
lucent and 5 echo-rich, Table 1) suggested that all carotid plaques
were mostly echo-lucent, thus rich in lipids and macrophages. This
is consistent with the clinical symptoms observed in most patients
of carotid plaque instability (n=25/29, Table S12).
To understand the role, if any, of plaque age for carotid plaque
stability, we investigated the IHC characteristics and their
associations with plaques of different ages. First, we grouped
the patients into terciles by plaque age (Table 1). The difference
in plaque age between the two extreme terciles was, as expected,
highly significant (Table 1, p=0.001). Carotid plaque echoge-
nicity did not differ between the terciles of plaque age (Table 2).
In contrast, in the lowest tercile of plaque age, the core fat
content (determined by Oil-Red-O staining; Fig. 2A) was 35%
higher (67.8612.4 vs. 50.466.2, p=0.00005) and the macro-
phage content (CD68 staining; Fig. 2B) was 45% higher
(57.6626.1 vs. 39.8625.7, p,0.0005) than in the highest tercile
(n=6 per tercile). Furthermore, the collagen and SM22 contents
were significantly lower (13%, 45.366.1 vs. 51.169.8, p,0.05,
and 8%, 130631 vs. 141621, p=0.05, respectively) than in the
highest tercile (Fig. 2C and D). These findings indicate that
plaque age distinguishes sublevels of instability of atherosclerotic
plaques and that a low plaque age, reflecting faster formation
time, is consistent with the IHC phenotype of more unstable
plaques.
Clinical characteristics of the patients in relation to
plaque age
The carotid stenosis patients (n=29) were typical for this kind of
cohort (Table 1). The average age was 68 years, 55% were males,
the average body mass index was just above 25, and blood
pressure (38% on beta blockers) and lipid levels (59% on statins)
were normal. Only two patients had a diagnosis of diabetes (7%).
Univariate Pearson correlation analyses (Table 2) of plaque age
in relation to other patient characteristics showed that the
strongest and only significant correlation was an inverse
correlation with plasma insulin levels (r=–0.59, p=0.0014).
Surprisingly, the correlation with patient age was weak and
statistically insignificant (r=0.34, p=0.09). In bivariate correla-
tion analyses (Table S1) that included the four most correlated
parameters from the univariate analyses (plasma insulin levels,
patient age, alanine transaminase, and gamma glutamyltransfer-
ase; Table 2), the inverse correlation with plasma insulin levels was
shown to be independent.
Two-way cluster analysis of global gene expression
profiles from the carotid plaques
Instead of examining the activity of individual genes in relation
to plaque age, we used two-way clustering [15,16] to identify
Clinical Phenotypes of Carotid Plaque Regeneration
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according to the mRNA signals of the microarrays. Recently, we
used this approach to identify a gene module of importance for the
extent of coronary atherosclerosis [14]. This approach generates
fewer false positives than gene-by-gene analysis; moreover,
bioinformatic analyses, such as Gene Ontology and KEGG
analyses using DAVID, are more suitable for identifying groups of
functionally related genes than a list of top-ranked differentially
expressed genes.
Gene expression profiles were generated from 25 carotid
plaques, 20 of which had been
14C dated. In the first step of the
two-way clustering analysis, 15,042 RefSeqs/12,621 genes were
Figure 1. The bomb curve and histogram of the carotid plaque age distribution. (A) The bomb curve. Carotid plaque samples were
14C
dated using AMS. The cellular birth dates can be inferred by determining the time at which
14C concentration of the sample corresponded to the
atmospheric concentration, using the Levin data as reference bomb curve. (B) Plaque age distribution in all carotid stenosis patients (n=29). The
interval is from 2–14 years, and all but two patients had plaque ages within a 10-year interval.
doi:10.1371/journal.pone.0018248.g001
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of eight clusters representing 904 RefSeqs/894 genes. Thus, the
carotid lesions harbored eight groups of functionally associated
genes active across all patients. In the second step, the patients
were clustered according to the RefSeqs signals within each of the
eight groups. One gene cluster (n=13 RefSeqs/genes) segregated
the patients into two groups that differed in average plaque age
(Fig. 3), suggesting that this cluster is important for plaque
formation. Plaque age correlated inversely with the mRNA signals
of the 13 genes in this cluster; that is, patients with low plaque
ages, and thus faster plaque formation time, had higher expression
levels and, as noted earlier, higher plasma insulin levels.
Table 1. Clinical characteristics of all patients and in terciles of these patients.
Characteristics
All patients
(n=29)
High plaque age
(n=10)*
Intermediate plaque age
(n=9)* p
Low plaque age
(n=10)* p
Plaque age (years) 9.6163.31 13.2361.25 9.4861.19 *** 6.1161.73 ***
Plaque start age (years) 58610 56686 3 695 7 612
Age (years) 68610 69687 2 696 3 612
Intima-media thickness (mm) 1.2560.23 1.4460.30 1.1360.17 1.1960.09
Gray-Weale scale (1–5) 2.2460.97 2.2561.49 2.0060.76 2.4460.53
Grayscale Median scale 25617 24619 20610 30619
Male 55 (16) 56 (5) 63 (5) 67 (6)
Body mass index (kg/m
2)2 5 . 1 63.6 24.264.1 25.862.7 25.563.9
Waist-to-hip ratio 0.9060.06 0.8760.04 0.9260.05 * 0.9260.07
Blood pressure (mm Hg)
Systolic 154619 155611 152624 155615
Diastolic 78687 6 687 9 610 7969
Insulin (pmol/L) 45618 31611 47615 * 57618 **
Proinsulin pmol/L 4.962.6 5.263.1 4.362.5 5.262.2
HbA1c (%) 4.960.5 5.160.6 4.660.4 5.060.4
C-reactive protein (mg/L) 10.5616.1 7.70610.27 9.40614.84 14.25621.99
Cholesterol (mmol/L)
Total 4.6461.12 4.7961.32 4.9661.26 4.2160.69
VLDL 0.2560.17 0.2860.22 0.2160.10 0.2660.16
LDL 2.5260.87 2.6060.96 2.8161.00 2.1960.60
HDL 1.6960.41 1.7560.54 1.7260.34 1.6160.33
Triglycerides (mmol/L)
Total 1.2960.46 1.3060.62 1.1960.32 1.3860.42
VLDL 0.8560.40 0.8860.60 0.7360.23 0.9260.32
LDL 0.3060.10 0.2860.08 0.3160.09 0.3060.12
HDL 0.1960.04 0.1960.04 0.1960.03 0.1960.05
Smoking status NA NA
Current 7 (2) 20 (2) 0 (0) 0 (0)
Former #2 years 38 (11) 40 (4) 63 (5) 22 (2)
Former .2 years 28 (8) 0 (0) 25 (2) 67 (6)
Nonsmoker 21 (6) 40 (4) 13 (1) 11 (1)
Alcohol consumption (g/week) 1026108 58653 1146164 142689 *
Diabetes mellitus 7 (2) 11 (1) 0 (0) 11 (1)
Insulin-requiring 3 (1) 0 (0) 0 (0) 11 (1)
Hyperlipidemia 48 (14) 56 (5) 63 (5) 44 (4)
Statins 59 (17) 44 (4) 57 (4) 100 (9)
Hypertension 62 (18) 78 (7) 75 (6) 56 (5)
Beta blocker 38 (11) 44 (4) 50 (4) 33 (3)
Values are mean 6 SD or % (n). HbA1c, glycated hemoglobin; VLDL, very low density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein; NA, not
applicable.
*p,0.05,
**p,0.01,
***p,0.001 vs. high plaque age group.
doi:10.1371/journal.pone.0018248.t001
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age
To learn more about genes related to plaque age, we performed
a Gene Ontology analysis with DAVID software. Of the 13 cluster
genes, five belonged to the biological process immune response
(p=0.001), and an additional three had previously been linked to
atherosclerosis [17,18,19,20]. These eight genes were phosphati-
dylinositol glycan class F (PIGF), with pro-angiogenic properties
[20]; adenosine monophosphate deaminase 1 (AMPD1), which is
involved in insulin clearance and was previously related to
cardiovascular morbidities [17,19]; tumor necrosis factor receptor
superfamily member 17 (TNFRSF17), which is essential for B-cell
development; Pou domain class 2 associating factor 1 (POU2AF1),
which is critical in B-cell-specific B29 promoter expression;
proapoptotic caspase adaptor protein (PACAP), a proapoptotic
regulator in lymphocytes [18]; X-box binding protein (XBP1), a
transcription factor that regulates major histocompatability
complex class II genes [21]; major histocompatibility complex
class II (HLA-DOB), which is expressed in antigen-presenting
cells; and immunoglobulin lambda-like polypeptide 3 (IGLL3).
The remaining five genes (DERL3, PIM2, FKBP11, FCRL5, and
NM_002694) have not been extensively studied (total PubMed
hits = 155) and have never before been linked to atherosclerotic
processes.
Single-gene analysis using the carotid plaque expression
profiles
A number of single-gene analyses were also performed, which in
general were less informative (Tables S2, S3, S4, S5, S6, S7, S8,
S9, S10, S11). For instance using Spearman rank correlations
between plaque age and individual mRNA levels, the 100 most
significantly associated genes with plaque age were unrelated to
atherosclerosis processes or pathways (Tables S2, S3, S4, S5). In
contrast, Spearman rank correlation between mRNA levels and
plaque ages performed within each tercile resulted in a group of
correlating genes in the low plaque age tercile that was
significantly enriched with genes in the oxidative phosphorylation
pathway (p=0.009) (Tables S6 and S9).
Discussion
In this study,
14C dating revealed that the cores of carotid
plaques have a much shorter, more uniform biological age, and
thus a faster formation time, than would be expected based on the
classic understanding of plaque maturation as a lifelong hetero-
geneous process. Instead, most plaques had formed over a
relatively short period of 5 to 10 years (5 to 15 years before
clinical symptoms and surgery), and the average subclinical
lifespan was ,9.6 years. The lack of correlation with the age of
the patients suggests that carotid plaques could either be formed
several times in a lifespan or, alternatively, just once relatively late
in life. A faster formation time (i.e., lower biological age) was
associated with features of unstable plaques (rich in macrophages
and fat, less collagen, and fewer smooth muscle cells). In addition,
plaque age was inversely related to plasma insulin levels suggesting
that insulin levels may be involved in determining plaque age.
Consistent with this notion, genes involved in immune responses
and oxidative phosphorylation were more active in plaques with
faster formation times.
Our findings suggest that a subtle increase in plasma insulin
levels, reflecting mild insulin resistance, increases the pace of
plaque formation, possibly by inducing gene activity involving
immune responses and oxidative phosphorylation. This would
lead to plaques with more macrophages and fat and less collagen,
which are more prone to rupture and cause clinical manifestations.
Theoretically, improved glucose control might be desirable to
prevent diabetes but also to increase plaque stability by prolonging
plaque formation time.
Plaque age did not, as might be expected, correlate with
chronological age or echogenicity. Thus, other contributing factors
may be more important for plaque formation. One obvious
possibility is inflammatory processes [8]. Elevated plasma insulin
levels were found to be associated with faster formation of the
plaques. Thus, mild insulin resistance may be central in increasing
the rate of plaque formation, leading to more instable plaques.
Indeed, insulin resistance increases levels of proinflammatory
cytokines and acute-phase mediators, a state that promotes plaque
Table 2. Univariate Pearson correlations with plaque age.
Phenotype Correlation p-value
Insulin -0.59 0.0014
logGT -0.34 0.08
Age 0.34 0.09
logALAT -0.34 0.09
Hemoglobin -0.31 0.13
logCreatinine 0.29 0.15
Waist-hip ratio -0.27 0.18
Diastolic blood pressure -0.27 0.19
Weight -0.26 0.20
HDL cholesterol 0.26 0.20
logFibrinogen 0.25 0.22
Plasma cholesterol 0.25 0.22
Waist -0.24 0.25
logAlcohol consumption
logVLDL TG
-0.22
-0.20
0.31
0.32
HbA1c 0.20 0.35
LDL cholesterol 0.18 0.37
Height -0.17 0.42
Body mass index -0.17 0.42
Thrombocytes -0.16 0.42
Echogenicity (Gray-Weale) -0.14 0.50
Plasma TG -0.12 0.56
Liver-type pyruvate kinase 0.12 0.58
Thyroid-stimulating hormone -0.10 0.62
Hip -0.09 0.67
logCRP -0.07 0.72
Heart rate 0.07 0.72
logVLDL cholesterol -0.06 0.77
logASAT -0.05 0.81
Proinsulin -0.03 0.87
HDL TG -0.03 0.87
Vmax 0.03 0.91
logLDL TG -0.01 0.96
Systolic blood pressure 0.00 0.99
GT, gamma-glutamyltransferase; ALAT, alanine aminotransferase; HDL, high
density lipoprotein; LDL, low density lipoprotein; VLDL, very low density
lipoprotein; TG, triglyceride; HbA1c, glycated hemoglobin; CRP, C-reactive
protein; ASAT, aspartate aminotransferase; LDL, low density lipoprotein.
doi:10.1371/journal.pone.0018248.t002
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[22,23,24]. Our finding that insulin levels are inversely correlated
with plaque age may also makes sense considering that elevated
plasma insulin levels act through many pathways [24,25] to
increase the growth rate and instability of carotid plaques,
consistent with symptomatic disease.
The global analysis of gene expression in the plaque core further
supports the notion that mild insulin resistance (only two patients
were diagnosed with diabetes) leads to faster plaque formation
time, possibly by triggering inflammation in the plaque (and more
inflammatory cells, as indicated by IHC analysis of CD68).
Indeed, most of the genes we identified as related to low plaque
age and faster formation time were associated with inflammatory
processes. In addition, the low plaque age samples were
significantly enriched with genes of the oxidative phosphorylation
pathway, a key driver of oxidative stress, which generates reactive
oxygen species, a potent contributor to unstable plaques [26].
Our results suggest that disease tissue formation time is an
important but overlooked aspect of disease development. Dating of
cardiomyocytes [13], fat cells [12], and neurons [27] has improved
our understanding of the etiology of several diseases. However, in
contrast to these earlier studies where they
14C dated DNA in
individual tissue cells [13,12,27], we investigated the entire cores of
atherosclerotic plaques that besides cells also consists of other types
of biological matters that likely is reprocessed both in and outside
cells (proteins, fat and necrotic material). For instance, a
substantial fraction of the plaque core consists of cholesterol-esters
(inside living and necrotic macrophages) originating from the
synthesis of fat, cholesterol and lipoprotein particles. The average
age of most core material is therefore likely older than its average
cell content. Indeed, this seemed to be the case since
14C dating
the core of carotid plaques indicated an average age of 9.6 years.
Or in other words, the
14C dating suggests a time of synthesis for
most of core matters some 10 years ago. Of course, the biological
age of different parts of the core might vary. However, when we
additionally
14C dated 2 carotid plaque cores divided into 2
random halves (thus 4 independent measurements), the results
showed that the variation in biological age between the two halves
Figure 2. IHC characteristics of plaque age. Representative sections of carotid cores from the terciles of highest (slower formation time) and
lowest (faster formation time) average plaque age (see Table 1). The IHC analyses were performed on 7-mm cryosections and stained (A) for lipids
with Oil-Red-O, (B) for macrophages with CD68 antibody, (C) for collagen with Masson’s trichrome, and (D) for smooth muscle cells with SM22
antibody. Bar charts present mean 6 SD.
doi:10.1371/journal.pone.0018248.g002
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together with relative limited standard variation (SD=3.3 years)
across all core samples suggest a much more coordinated time
period for the formation of the plaque cores than perhaps
expected, with limited contribution of de-novo synthesized
biological matter thereafter.
In accordance, the interpretation of the current
14C dating
measurements could only with certainty determine the most recent
plaque formation time and probably say very little, if anything,
about previous reformations and thus plaque regeneration. In fact,
it is unclear if the majority of the atherosclerotic plaque core
regenerates at all (i.e. whether the plaques are reformed several
time in a life span or not). Although an average age of 9.6 years
suggests that the plaque core very well could regenerate several
times in a life span, this will depend on when plaque cores are first
formed. Regardless, our study supports the notion that
14C dating
of entire lesions of diseased tissues (e.g. atherosclerotic plaques,
tumors) provides another, but seemingly relevant, type of
information than studies performing
14C dating of DNA.
In summary, our study of plaque age in relation to clinical and
molecular features in carotid stenosis patients revealed that plaque
formation time is relevant for plaque stability and therefore risk of
clinical events. Interestingly, a recent study of eight carotid stenosis
patients used
14C dating to investigate formation time of different
components of the carotid plaques [28]. Our findings show that
14C dating has the potential to deepen our understanding of
atherogenesis and its clinical consequences. Additional and larger
studies including
14C dating of atherosclerotic plaques are
warranted.
Materials and Methods
Ethics Statement
The study was approved by the Ethics Committee of Karolinska
University Hospital and all patients gave written informed consent.
Study patients and carotid biopsies
Forty-two patients undergoing carotid surgery at Stockholm
So ¨der Hospital were used in this study [14]. At surgery, the core of
the carotid plaque was extracted through an incision in the far
common arterial wall, embedded in OCT compound (Histolab
Products), snap frozen in liquid isopentane and dry ice, and stored
at –80uC. Random thirds of the carotid core were used for RNA
isolation, IHC, and
14C dating. Thirty-nine patients came to a 3-
month follow-up visit. Using a standard questionnaire, a research
nurse obtained a medical history and lifestyle information (e.g.,
smoking, alcohol consumption, and physical activity). A physical
examination was performed, and venous blood was sampled.
14C dating of carotid plaques
AMS was used to determine the average formation time of 29
randomly selected cores of the carotid plaques as described
[10,12,13,29]. In brief, a 5 MV Pelletron tandem accelerator
(NEC) was used to measure the
14C:
12C isotopic ratio. The carotid
Figure 3. An mRNA cluster segregating patients according to plaque ages. To identify groups of functionally related genes important for
plaque age, a two-way clustering approach was used [14]. In the first step, the cluster algorithm is used to determine the total number of functionally
related gene groups (i.e., gene clusters) in the carotid plaques calculated from 24 gene expression profiles. Eight gene clusters were identified. In the
second step, one cluster (n=13 RefSeqs/genes) segregated the carotid stenosis patients into two groups that differed significantly in plaque age
(p=0.04), suggesting that these genes could be involved in this plaque formation. Eight of the 13 genes were related to immune or inflammatory
processes linked to atherosclerosis.
doi:10.1371/journal.pone.0018248.g003
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few milligrams of tissue were placed in a quartz tube with 80 mg of
CuO as the oxidizing agent. The tube was flame-sealed and baked
at 950uC for 3 hours to produce CO2. The gas was cryogenically
transferred in vacuum to a vial containing 80 mg of zinc powder as
the reducing agent and 2 mg of iron powder as the catalyst. The
sealed vial was baked at 530uC for 6 hours, and the graphite
produced (,1 mg) was pressed and loaded into the ion source of
the accelerator. Each sample was analyzed during four 5-minute
data acquisition periods. After each period, a reference sample
(oxalic acid II, NIST) was measured. To correct for fractionation
effects, the
13C:
12C ratio of a small part of the CO2 gas was
measured with an off-line isotope ratio mass spectrometer (Fisons/
VG-Isotech 652-Optima). The fractionation-corrected isotopic
ratios were presented in fraction modern F
14C, and the average
formation year was extracted [30] based on measurements of CO2
variation in northern Europe [9].
IMT and echogenicity assessed by B-mode ultrasound
Before surgery, carotid arteries were examined with B-mode
ultrasound. The far wall of the common carotid artery was used to
measure IMT from the endarterectomy side [31]. In addition, The
echogenicity of plaques were determined using Gray-Weale
[32,33,34] and Grayscale Median [35,36,37] scales.
Global gene expression profiling of carotid plaque core
RNA from one third of the carotid plaque core was isolated
using Trizol (BRL-Life Technologies), FastPrep (MP Biomedicals),
and RNeasy Mini kit (Qiagen) with a DNase 1 treatment step
(Qiagen). Sample quality was assessed with an Agilent Bioanalyzer
2100. cRNA yield was assessed with a spectrophotometer (ND-
1000, NanoDrop Technologies) before hybridization to HG-U133
Plus 2.0 arrays (Affymetrix). The arrays were processed with a
Fluidics Station 450, scanned with a GeneArray Scanner 3000,
and analyzed with GeneChip Operational Software 2.0.
Data pre-processing and clustering
Gene expression values were pre-processed with quantile
normalization and the robust multichip average [38]. Of
604,258 perfect-match Affymetrix probe signals, 280,523 could
be mapped to 16,685 Entrez genes without cross-hybridizing
probes [14].
Coupled two-way clustering [15,16,39] was performed to
identify small, stable clusters of related signals. In the first step,
clusters were defined by superparamagnetic clustering [39], with
the absolute value of Spearman rank correlation as a distance
measure between genes. Genes that did not belong to a cluster
were excluded. In the second step, the identified clusters were
related to plaque age by hierarchical clustering [40] of the patients,
using Manhattan distance and average linkage as distance
measures, based on the mRNA signals in each of the clusters
defined in the first step [14].
Immunohistochemistry
IHC was performed on cryosections (7 mm) from the carotid
plaque core. For analyses of CD68 and smooth muscle cells (SM22
alpha), the sections were fixed in acetone. Endogenous peroxidase
activity was quenched with 0.3% hydrogen peroxide/0.01% NaN3
in water for 10 min, and the sections were incubated with 5%
blocking serum. Consecutive sections were incubated with
monoclonal mouse anti-human CD68 (Novocastra Laboratories)
or polyclonal rabbit anti-human SM22 alpha (transgelin, Abcam)
at 4uC overnight. In negative controls, primary antibody was
replaced with PBS. After rinsing in Tris-buffered saline, sections
were incubated with secondary biotinylated bovine anti-mouse or
anti-rabbit (Vector Laboratories). Avidin-biotin peroxidase com-
plexes (Vectastain ABC Elite, Vector Laboratories) were added
followed by visualization with diaminobenzidine (Vector Labora-
tories). All sections were counterstained with Gill hematoxylin
(Histolab Products AB). For analysis of collagen, the sections were
stained with Masson’s trichrome stain (Sigma-Aldrich). Lipid
content was analyzed by Oil-Red-O staining, as described [41].
VectaMount (Vector Laboratories) was used as the mounting
medium in all experiments. The extent of staining in different
sections of the carotid core was assessed with Adobe Photo Shop
CS3.
Statistical analysis
Clinical, IHC, and metabolic characteristics are given as
continuous variables with means and standard deviations and as
categorical variables with numbers and percentages of subjects.
For continuous variables, p-values were calculated with unpaired t
tests; skewed values were log-transformed. For categorical
variables, chi-square or Fisher’s exact text (n,5) was used. The
correlation analysis was performed with Spearman rank correla-
tion, using p-values from t tests after Fisher transformation. Models
of interest were identified by multiple step-wise regression analysis.
Mathematica 6.0 or SAS 9.0 was used for all calculations.
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